Delivery Order SPE2DB22D9353-SPE2DB24FX1YX

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,818.04, is for the delivery of 4564600789 CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through May 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of CABOMETYX 20 MG TABLET 30S, a branded prescription drug, with a ceiling value of $62,384.88 and a period of performance through November 2024. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,632.54 contract is for the delivery of 4567008408 - CABOMETYX 20 MG TABLET 30S, a prescription drug product, with a period of performance through January 23, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,221.97 contract was awarded by the Defense Logistics Agency (DLA) to supply the drug CABOMETYX 40 MG TABLET 30S. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract has a firm fixed price of $30,818.04 and provides the DLA with CABOMETYX 40 MG TABLET 30S pharmaceutical products. This order is part of a larger indefinite delivery vehicle (IDV) contract #4600082013 between DMS Pharmaceutical Group and the DLA, valued at up to $4,999,999 through 2025, which enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $96,405.12, is for the delivery of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $93,577.32 firm fixed-price contract is for the delivery of CABOMETYX 20 MG TABLET 30S, a cancer medication. The contract has an ultimate completion date of November 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of CABOMETYX 20 MG TABLET 30S. The firm fixed-price contract has a ceiling value of $15,596.22 and an ultimate completion date of March 13, 2024. This delivery order is issued against an Indefinite Delivery Vehicle (IDV) contract, SPE2DB20D9354, held by DMS Pharmaceutical Group with DLA, which enables DLA to order a broad range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical products. The contract, valued at $15,596.22, covers the delivery of CABOMETYX 20 MG TABLET 30S through March 2024. This order is part of DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, valued at up to $4,999,999 through 2025, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $30,818.04 and has an ultimate completion date of January 12, 2024. The delivery order is for the pharmaceutical product CABOMETYX 40 MG TABLET 30S. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX1YX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a prescription medication, with a ceiling value of $15,454.70. The contract has a firm fixed-price pricing type and an ultimate completion date of June 6, 2024.

DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle under the SPE2DB program allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This delivery order is part of that larger IDC contract. The contract does not have a set-aside designation.

Generated 9/4/24, 9:30 AM